NCOA2
Chr 8nuclear receptor coactivator 2
Also known as: GRIP1, KAT13C, NCoA-2, SRC-2, SRC2, TIF2, bHLHe75
The NCOA2 protein functions as a transcriptional coactivator for nuclear hormone receptors, including steroid, thyroid, retinoid, and vitamin D receptors, and plays a critical role in glucose metabolism regulation and circadian clock function. Mutations in NCOA2 cause neurodevelopmental disorders with variable features including intellectual disability, developmental delay, and growth abnormalities, typically with autosomal dominant inheritance. This gene is highly constrained against loss-of-function variants in the general population, indicating that such mutations are likely to be pathogenic when they occur.
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Among the most LoF-intolerant genes (~top 3%)
Moderately missense-constrained (top ~2.5%)
The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).
Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.
ClinVar Variant Classifications
0 submitted variants in ClinVar
Protein Context — Lollipop Plot
NCOA2 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
No active trials found for this gene.
Search ClinicalTrials.gov →External Resources
Links to major genomics databases and tools